LEVOCAR 330 mg is used in the treatment of Parkinson’s disease and Parkinson-like symptoms. Levodopa is converted to dopamine in the brain, helping control movement, while Carbidopa prevents the breakdown of Levodopa before it reaches the brain, enhancing its effectiveness and reducing side effects like nausea.